FDA Approved: NULOJIX — Original Application (E.R. Squibb & Sons, L.L.C.)

View source ↗

Summary

FDA approved NULOJIX (belatacept) via its original biologics license application for the prevention of kidney transplant rejection in adult recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Drugs mentioned

• Nulojix (belatacept)

Snippet

ORIG AP for NULOJIX (BELATACEPT)